Molecular control of bone remodeling and osteoporosis
- 31 October 2000
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 35 (8) , 947-956
- https://doi.org/10.1016/s0531-5565(00)00178-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- RANKing the importance of measles virus in Paget’s diseaseJournal of Clinical Investigation, 2000
- Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank InteractionThe Journal of Experimental Medicine, 2000
- A Chimeric Form of Osteoprotegerin Inhibits Hypercalcemia and Bone Resorption Induced by IL-1β, TNF-α, PTH, PTHrP, and 1,25(OH)2D3Journal of Bone and Mineral Research, 1999
- The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature OsteoclastsThe Journal of cell biology, 1999
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Tumor Necrosis Factor-α and -β Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 CellsBiochemical and Biophysical Research Communications, 1998
- Regulation of Osteoprotegerin mRNA Levels by Prostaglandin E2in Human Bone Marrow Stroma CellsBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996